Background: Biological therapies have substantially improved clinical outcomes in inflammatory bowel disease (IBD); however, the relationship between long-term biologic therapy, disease remission, and gut microbiome characteristics remains incompletely understood. This pilot study aimed to characterize the taxonomic co...
Sergiu-Ioan Frandes, Oana Frandeș, Melania Macarie et al.· Journal of Clinical Medicine· 0 citations
Current evidence does not support its use as a standalone diagnostic or prognostic biomarker in critical illness, and further prospective studies using standardized measurement protocols and serial assessment are needed to determine its potential role alongside clinical evaluation and complementary biomarkers.
Oana Frandeș, A. Lazăr, Sergiu-Ioan Frandes et al.· Diagnostics· 0 citations
This review examines apoptosis-associated biomarkers in sepsis, distinguishing relatively direct markers of cell death from complementary indicators of immune dysfunction, inflammation, and organ injury, and considers their potential for longitudinal monitoring.
Oana Coman, L. Azamfirei, Oana Frandeș et al.· Biosensors· 0 citations
AI has considerable potential to support AMR prediction and antimicrobial stewardship, but broader implementation will require rigorous validation, integration into clinical workflows, continuous monitoring and demonstration of clinical benefit.
Oana Frandeș, L. Azamfirei, Oana-Elena Branea et al.· Medicina· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.